Medication info

Ranidro Tablets (Ranitidine Hydrochloride)

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tablet
Manufacturer / importer
Independence Bio Pharmaceutical Co., Ltd.
Appearance
Off-white to yellowish round film-coated tablet
Packaging
For domestic use - 30 tablets/bottle, For domestic use - 100 tablets/bottle
Approval status
Expired

MFDS item code 201906108 · Approved 2019.08.28

This product's status changed to Expired on 2024.08.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (including ulcers), improvement of gastric mucosal lesions, and prevention of Mendelson's syndrome
Who takes it
Adults · Children
Adult dose
Administer ranitidine 150 mg orally twice daily, in the morning and at bedtime. Gastric and duodenal ulcers: Administer 150 mg of this medicine orally twice daily, or 300 mg once daily at bedtime. In particular, a higher rate of healing may be achieved in patients with duodenal ulcers by administering 300 mg twice daily, in the morning and at bedtime. The same dosage applies to concomitant use to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks; conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. Gastroesophageal reflux disease: Administer 150 mg of this medicine twice daily for 8 weeks, or 300 mg once daily before bedtime. The dose may be increased to 150 mg 4 times daily in patients with severe gastroesophageal reflux disease. Zollinger-Ellison syndrome: Initiate treatment with an initial dose of 150 mg of this medicine 3 times daily; the dose may be increased as needed. For severe disease, doses of up to 6 g per day may be administered as directed by a physician. For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injection; once oral administration is possible, switch to oral administration of 150 mg of this medicine twice daily. Preanesthetic medication (prevention of Mendelson's syndrome): Administer 150 mg of this medicine 2 hours before induction of anesthesia. It is also preferable to administer 150 mg on the night before surgery. Improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) associated with the following conditions: acute gastritis and acute exacerbation of chronic gastritis: Administer 150 mg of this medicine once daily at bedtime. Patients with renal impairment: For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the medicine; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.
Child dose
Patients aged 12 years and older: For hyperacidity, heartburn, and acid regurgitation, administer 75 mg of this medicine orally twice daily (liquid formulation only). Ages 8 〜 18: 150 mg per dose (2 mg/kg of body weight), up to twice daily

Ingredients

Manufacturer
Independence Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (including ulcers), improvement of gastric mucosal lesions, and prevention of Mendelson's syndrome

  • Gastric and duodenal ulcers
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers due to NSAID administration
  • gastric mucosal lesions
  • erosion
  • bleeding
  • redness
  • swelling
  • acute gastritis
View approved original text

This medication is used in the treatment of conditions such as gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also effective for the prevention of Mendelson's syndrome before anesthesia, treatment of postoperative ulcers, and gastric ulcers induced by NSAIDs. It helps alleviate the exacerbation of acute and chronic gastritis, and improves lesions such as gastric mucosal erosion, bleeding, redness, and swelling. Furthermore, it treats peptic ulcers, acute stress ulcers, and gastric mucosal bleeding and is used to relieve symptoms such as heartburn and belching due to excessive gastric acid. Overall, it is effective in protecting gastric mucosa and improving gastric acid issues.

How to take

Adult dose

Administer ranitidine 150 mg orally twice daily, in the morning and at bedtime. Gastric and duodenal ulcers: Administer 150 mg of this medicine orally twice daily, or 300 mg once daily at bedtime. In particular, a higher rate of healing may be achieved in patients with duodenal ulcers by administering 300 mg twice daily, in the morning and at bedtime. The same dosage applies to concomitant use to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks; conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. Gastroesophageal reflux disease: Administer 150 mg of this medicine twice daily for 8 weeks, or 300 mg once daily before bedtime. The dose may be increased to 150 mg 4 times daily in patients with severe gastroesophageal reflux disease. Zollinger-Ellison syndrome: Initiate treatment with an initial dose of 150 mg of this medicine 3 times daily; the dose may be increased as needed. For severe disease, doses of up to 6 g per day may be administered as directed by a physician. For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injection; once oral administration is possible, switch to oral administration of 150 mg of this medicine twice daily. Preanesthetic medication (prevention of Mendelson's syndrome): Administer 150 mg of this medicine 2 hours before induction of anesthesia. It is also preferable to administer 150 mg on the night before surgery. Improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) associated with the following conditions: acute gastritis and acute exacerbation of chronic gastritis: Administer 150 mg of this medicine once daily at bedtime. Patients with renal impairment: For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the medicine; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.

Child dose

Patients aged 12 years and older: For hyperacidity, heartburn, and acid regurgitation, administer 75 mg of this medicine orally twice daily (liquid formulation only). Ages 8 〜 18: 150 mg per dose (2 mg/kg of body weight), up to twice daily

Precautions

This medication should not be used in patients who have previously shown allergic reactions to its components. Patients who have suffered from a rare blood disorder called acute porphyria should also use this medication with caution. Patients with impaired kidney function may require dosage adjustments as this medication can remain in the body for a longer period. Caution is also required when using this medication in patients with liver impairment. Patients with a history of drug allergies or elderly patients must exercise special care when taking this medication. Regular check-ups are necessary for patients taking NSAIDs, particularly elderly patients or those with a history of peptic ulcers. This medication may mask the symptoms of gastric cancer, so patients with gastric ulcers or new dyspeptic symptoms over the age of middle age should verify the malignancy before treatment. Patients with gastric or duodenal ulcers infected with Helicobacter pylori should receive bacterial eradication therapy concurrently. While rare, serious allergic reactions such as anaphylactic shock may occur during the course of treatment, and if any unusual symptoms appear, the use of this medication should be discontinued immediately. If allergic symptoms such as hives, rashes, difficulty in breathing, or hypotension occur, the medication should be stopped and medical advice should be sought. Blood-related side effects, such as leukopenia or thrombocytopenia, may occur infrequently, so testing is necessary if symptoms like fatigue, bleeding, or fever arise. Liver function impairment may occur, so if symptoms of jaundice, fatigue, or loss of appetite develop, medical personnel should be informed immediately. Rare symptoms of circulatory system abnormalities, such as cardiac arrhythmia or vasculitis, have also been reported, so care is needed. Gastrointestinal side effects such as constipation, nausea, abdominal pain may occur. Neuropsychiatric side effects such as dizziness, drowsiness, headache, or mental confusion may be present, thus it is advisable to avoid driving or operating dangerous machinery. If muscle pain or joint pain arises, inform a doctor and receive appropriate measures. Skin-related side effects such as rashes or hair loss may also occur rarely. This medication can affect kidney and liver function, necessitating regular blood tests and liver function tests. Elderly patients or those with chronic conditions may have an increased risk of pneumonia, thus care should be taken. When taking this medication with other drugs, the therapeutic effects may change, so inform healthcare providers about currently used medications. Women who are pregnant or breastfeeding should only use this medication when absolutely necessary, as its safety has not been sufficiently established. The safety of this medication in children has not been adequately confirmed, so it should be used with caution. While special overdose symptoms are rare, emergency measures such as vomiting or gastric lavage may be necessary. This medication should be kept out of reach of children and not transferred to other containers.

Side effects

  • Anaphylactic shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • elevated serum creatinine
Show 57 more
  • leukopenia
  • thrombocytopenia
  • aplastic anemia
  • pure red cell aplasia
  • refractory anemia
  • agranulocytosis
  • pancytopenia
  • acquired hemolytic anemia
  • eosinophilia
  • general malaise
  • weakness
  • subcutaneous and mucosal bleeding
  • liver dysfunction
  • jaundice
  • hepatitis
  • bradycardia
  • heart block
  • tachycardia
  • vasculitis
  • constipation
  • nausea
  • vomiting
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • convulsions
  • headache
  • heaviness in the head
  • insomnia
  • agitation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurry vision
  • involuntary movement disorders
  • consciousness disturbance
  • hepatic myoclonus
  • gynecomastia
  • excessive milk secretion
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • stomatitis
  • pruritus
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a container that does not allow light to enter. Additionally, it should be kept at a temperature between 1 and 30 degrees Celsius for safe use.

Appearance and packaging

Appearance

Off-white to yellowish round film-coated tablet

Package unit

For domestic use - 30 tablets/bottle, For domestic use - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.